1249693

Rite-Kem Incorporated — FEI 1000337046

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 12, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tupelo, MS (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
121521 CFR 211.67(b)Written procedures not established/followed
136121 CFR 211.100(a)Absence of Written Procedures
145421 CFR 211.115(a)Reprocessing procedures not written or followed
162621 CFR 211.130Procedures are written, and followed
176721 CFR 211.137(a)Expiration date lacking
184221 CFR 211.84(d)(1)Component identity verification
188321 CFR 211.165(a)Testing and release for distribution
194321 CFR 211.180(e)(1)Review of representative number of batches
200921 CFR 211.188Prepared for each batch, include complete information
241921 CFR 211.198(a)Complaint Handling Procedure
433821 CFR 211.150(b)Recall facilitation